about
Brentuximab vedotin combined with donor lymphocyte infusions for early relapse of Hodgkin lymphoma after allogeneic stem-cell transplantation induces tumor-specific immunity and sustained clinical remission.CD40-activated B cells induce anti-tumor immunity in vivo.Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma.CD40-activated B cells as antigen-presenting cells: the final sprint toward clinical application.A multimerized form of recombinant human CD40 ligand supports long-term activation and proliferation of B cells.Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy.Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation, resulting in a reduced capacity to induce T cell immunity.CD30-targeted therapy with brentuximab vedotin and DLI in a patient with T-cell posttransplantation lymphoma: induction of clinical remission and cellular immunity.Cyclin A1, a promising tumor antigen: the devil is in the amino acids.Prospective Analyses of Circulating B Cell Subsets in ABO-Compatible and ABO-Incompatible Kidney Transplant Recipients.Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma
P50
Q33405002-A08B14AD-7B43-4E51-B590-740D6F8BF0E7Q33709425-03498935-1CC7-40E0-AAD1-14E28B14C249Q34103969-95C74FBF-68D5-4DB7-B72F-72DD23028B21Q37012537-68BE363D-3DA5-4AE4-BB65-8EE2D554BF5CQ38113268-B25C2CA6-631F-42A1-B44E-48BA95B50453Q39117820-B0C24BE1-9CFC-4BAD-9225-62323DE7E0B8Q40475503-B371ED09-B56E-471F-AB15-63031218F4E5Q40502860-305C8AC3-343E-4815-B1CD-D93AC4678B64Q41703131-E1A912A9-26F1-4894-9FC1-13263105B8EDQ44330666-B7455BFD-DE78-47C8-869E-6DF20F027F11Q44908063-9701270F-7558-4589-B7E7-C782E5AD74F4Q48109603-3C80C759-1277-46D0-9F81-1F032113F24FQ63979891-14AB34ED-7F85-48F3-9358-C2F4423A0862
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kerstin Wennhold
@ast
Kerstin Wennhold
@en
Kerstin Wennhold
@es
Kerstin Wennhold
@nl
type
label
Kerstin Wennhold
@ast
Kerstin Wennhold
@en
Kerstin Wennhold
@es
Kerstin Wennhold
@nl
prefLabel
Kerstin Wennhold
@ast
Kerstin Wennhold
@en
Kerstin Wennhold
@es
Kerstin Wennhold
@nl
P106
P108
P31
P496
0000-0001-5539-7226